Pathogenic cellular phenotypes are germline transmissible in a transgenic primate model of Huntington's disease

Kittiphong Putkhao1, Jannet Kocerha, In-Ki Cho

  • 1Yerkes National Primate Research Center, Atlanta, Georgia, USA.

Stem Cells and Development
|November 30, 2012
PubMed

Insights

Researchers achieved germline transmission of the Huntington

Area of Science:

  • Neuroscience
  • Genetics
  • Stem Cell Biology

Background:

  • Huntington's Disease (HD) is a neurodegenerative disorder characterized by motor, cognitive, and psychiatric deficits.
  • Existing transgenic primate models exhibit motor symptoms but lack robust germline transmission of the causative gene.
  • Developing a primate model with inherited mutant Huntingtin (HTT) is crucial for studying HD pathogenesis and therapeutics.

Purpose of the Study:

  • To report the germline transmission of the mutant HTT gene in a transgenic primate model of Huntington's Disease.
  • To derive and characterize Huntington's Disease monkey embryonic stem cells (rHD-ESCs) from germline-transmitted embryos.
  • To establish a primate model that replicates key cellular and genetic features of human Huntington's Disease.

Main Methods:

  • Utilized a previously established transgenic primate model carrying the mutant HTT gene with expanded CAG repeats.
  • Produced embryos via in vitro fertilization using sperm from affected male monkeys.
  • Derived and cultured rHD-ESCs, confirming inheritance of the mutant HTT and GFP transgenes.

Main Results:

  • Successfully achieved germline transmission of the mutant HTT gene through gametes.
  • Derived rHD-ESCs express the mutant HTT protein and form intranuclear inclusions, a hallmark of HD.
  • Observed mosaicism in the polyglutamine (CAG) repeat region in sperm and derived ESCs, consistent with human HD observations.

Conclusions:

  • This study establishes a milestone by confirming transgene inheritability and the development of HD phenotypes in derived rHD-ESCs.
  • The rHD-ESC line provides a valuable platform for studying HD pathogenesis and developing novel biomarkers and therapeutics.
  • This model offers unprecedented opportunities for preclinical testing of gene-targeted therapies in a primate system.